Status:
TERMINATED
Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit
Lead Sponsor:
Clinical Research Centre, Malaysia
Collaborating Sponsors:
Hospital Queen Elizabeth, Malaysia
Conditions:
Covid19
Critically Ill
Eligibility:
All Genders
Brief Summary
Studying clinical characterization of critically ill COVID-19 patients in a single center Studying Risk factors for Day 28 Mortality in COVID-19 patients admitted to intensive care unit
Detailed Description
An observational study looking into clinical characterization of the novel Coronavirus Disease 2019 (COVID-19) in patients admitted, critically ill, into Intensive Care Unit of Hospital Queen Elizabet...
Eligibility Criteria
Inclusion
- All patients admitted to the ICU in Hospital Queen Elizabeth, Kota Kinabalu between 1st October 2020 until 31st January 2021
- Confirmed COVID-19 Positive using RT-PCR or RTK-Ag either before or during admission in ICU
Exclusion
- Patients that were admitted in ICU suspected to have COVID-19 and died in ICU which subsequently to be COVID-19 negative
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04805645
Start Date
April 1 2021
End Date
May 1 2021
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Queen Elizabeth
Kota Kinabalu, Malaysia